Results 11 to 20 of about 1,949 (176)

Modelling of icodextrin hydrolysis and kinetics during peritoneal dialysis

open access: yesScientific Reports, 2023
In peritoneal dialysis, ultrafiltration is achieved by adding an osmotic agent into the dialysis fluid. During an exchange with icodextrin-based solution, polysaccharide chains are degraded by α-amylase activity in dialysate, influencing its osmotic ...
Joanna Stachowska-Pietka   +5 more
doaj   +2 more sources

Dermatitis Secondary to Hypersensitivity to Icodextrin is a Rare Complication of Icodextrin Therapy in Peritoneal Dialysis

open access: yesProceedings of Singapore Healthcare, 2012
Case report on dermatitis secondary to hypersensitivity to icodextrin, which is a rare complication of icodextrin therapy in peritoneal dialysis.
Ru Yu Tan MBBS (M'sia), MRCP (UK)   +2 more
doaj   +2 more sources

Use of Toll-like receptor assays for the detection of bacterial contaminations in icodextrin batches released for peritoneal dialysis

open access: yesToxicology Reports, 2017
Icodextrin is a starch derivative used for preparing solutions of peritoneal dialysis. Unfortunately, peptidoglycans (PGN) and lipopolysaccharides (LPS) have been reported to contaminate certain icodextrin batches and to contribute to the development of ...
Hêla Hacine-Gherbi   +6 more
doaj   +2 more sources

Clinical rationale behind glucose-sparing strategies in peritoneal dialysis: a narrative review [PDF]

open access: yesBMC Nephrology
The effectiveness of peritoneal dialysis (PD) relies on dialysate-induced solute and water transport across the peritoneal membrane, facilitated by concentration and type of osmotic agents.
Bengt Lindholm   +13 more
doaj   +2 more sources

Glucose-Free Solutions Mediated Inhibition of Oxidative Stress and Oxidative Stress-Related Damages in Peritoneal Dialysis: A Promising Solution [PDF]

open access: yesLife
Oxidative stress (OxSt) and inflammation are common in end-stage renal disease and dialysis patients; they are known risk factors for cardiovascular disease and mortality.
Anna Basso   +4 more
doaj   +2 more sources

Prevention of Intraabdominal Adhesions: An Experimental Study Using Mitomycin-C and 4% Icodextrin

open access: yesBalkan Medical Journal, 2017
Background: Intraabdominal adhesions remain a significant cause of morbidity and mortality. Moreover, intraabdominal adhesions can develop in more than 50% of abdominal operations.
Murat Urkan   +6 more
doaj   +2 more sources

Bimodal Solutions or Twice-Daily Icodextrin to Enhance Ultrafiltration in Peritoneal Dialysis Patients

open access: yesInternational Journal of Nephrology, 2013
The efficacy and safety of icodextrin has been well established. In this paper, we will discuss the pharmacokinetics and biocompatibility of icodextrin and its clinical effect on fluid management in peritoneal dialysis patients.
Periklis Dousdampanis   +2 more
doaj   +2 more sources

Adhesion-preventing properties of 4% icodextrin and canola oil: a comparative experimental study

open access: yesClinics, 2012
OBJECTIVE: Postsurgical abdominal adhesions are common, serious postoperative complications. The present study compared the usefulness of 4% icodextrin and canola oil in preventing postoperative peritoneal adhesions.
Cengizhan Yigitler   +5 more
doaj   +2 more sources

Icodextrin as salvage therapy in peritoneal dialysis patients with refractory fluid overload [PDF]

open access: yesBMC Nephrology, 2001
Background Icodextrin is a high molecular weight, starch-derived glucose polymer, which is capable of inducing sustained ultrafiltration over prolonged (12–16 hour) peritoneal dialysis (PD) dwells.
Watt Rhonda   +5 more
doaj   +2 more sources

Icodextrin reduces adhesion formation following gynecological surgery in rabbits [PDF]

open access: yesIranian Journal of Reproductive Medicine, 2011
Background: Adhesion is a common complication of gynecology surgery so different barrier agents and solutions have been used during these operations to separate and protect tissues from adhesion after surgery.
Behnaz Khani1   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy